Longevity & AgingGDF-15 predicts death and bleeding after heart attack but cannot diagnose one
GDF-15 is a stress-induced signaling protein that rises with ischemia, inflammation, kidney disease, frailty and aging. This narrative review of acute coronary syndrome (ACS) literature concludes that it is a poor test for diagnosing heart attack (AUC about 0.69 vs 0.96 for troponin) but a strong prognostic marker. Higher levels track with all-cause and cardiovascular death, heart failure and major bleeding, and less specifically with recurrent heart attack. In a 4,779-patient emergency cohort, 90-day and 5-year mortality C-indices were 0.86 and 0.84. Evidence is associational. There are no validated thresholds, and no trial shows GDF-15-guided care improves outcomes, so routine use to guide antiplatelet therapy is unsupported. The provided text is truncated before the incremental-value results.